Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Lindsay Kilburn

Associate Professor

George Washington University

United States

Research Interests

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (7)

Marie Jaeger-Krause

Assistant Professor

University of California, San Francisco

UNITED STATES

View details

Adriana Fonseca

Assistant Professor

George Washington University

UNITED STATES

View details

Nicholas Gottardo

University of Western Australia

AUSTRALIA

View details

Arzu Onar-Thomas

Member

St. Jude Children's Research Hospital

UNITED STATES

View details

Siva Kumar Natarajan

University of Michigan

UNITED STATES

View details

Sandeep Dhanda

Lead Bioinformatics Research Scientist

St. Jude Children's Research Hospital

UNITED STATES

View details

Jung Woo Han

Assistant Professor

Yonsei Cancer Center

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lindsay Kilburn

Research Interests

Explore related searches

Articles (20)

Efficacy Study of Vemurafenib in Children With Recurrent or Progressive BRAF V600E - or BRAF InsT -Mutant Brain Tumors: PNOC002

PNOC014: Phase I Study of Tovorafenib for Children With Relapsed/Recurrent Low-Grade Gliomas and Other Mitogen Activated Protein Kinase Pathway–Activated Tumors

Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial

A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Clinical stability following tovorafenib treatment in relapsed/refractory pediatric low-grade glioma: updated results from the phase 2 FIREFLY-1 trial

PHASE 2 STUDY OF ALISERTIB IN COMBINATION THERAPY FOR NEWLY DIAGNOSED ATYPICAL TERATOID/RHABDOID TUMOR (AT/RT)- RESULTS FROM SJATRT STRATA B AND C

Repurposing Thyroid Hormone to Improve Chemotherapy Outcome for Medulloblastoma

Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG

MR-guided focused ultrasound in pediatric neurosurgery: current insights, technical challenges, and lessons learned from 45 treatments at Children’s National Hospital

A road map for the treatment of pediatric diffuse midline glioma

A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas (vol 19, pg 774, 2017)

CEREBROSPINAL FLUID DIVERSION DOES NOT PROLONG OVERALL SURVIVAL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A REPORT FROM THE INTERNATIONAL DIPG REGISTRY

COMBINED PRECLINICAL AND CLINICAL INVESTIGATION OF WHICH PEDIATRIC HIGH-GRADE GLIOMA SUBTYPES BENEFIT FROM CCNU/TEMOZOLOMIDE

EARLY INSIGHTS FROM PNOC027: PERSONALIZED TREATMENT APPROACHES BASED ON REAL-TIME DRUG SCREENING AND GENOMIC TESTING IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RECURRENT MEDULLOBLASTOMA

HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)

INTERIM CLINICAL, PHARMACOKINETIC, AND TECHNICAL REPORT OF A PHASE 2 STUDY OF SONODYNAMIC THERAPY (SDT) USING SONALA-001 TOGETHER WITH MR-GUIDED LOW-INTENSITY FOCUSED ULTRASOUND (MRGFUS) IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating <i>RAF</i> alteration

Molecular-targeted therapy for childhood low-grade glial and glioneuronal tumors

Collaborators (7)

Marie Jaeger-Krause

Adriana Fonseca

Nicholas Gottardo

Arzu Onar-Thomas

Siva Kumar Natarajan

Sandeep Dhanda

Jung Woo Han

Make your next move.